SONN Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SONN shares is 3, representing 0.2% of the company's common stock.

TOWER RESEARCH CAPITAL LLC (TRC), in the last quarter, reduced its stake in SONN by -100% restricting it's holding to 0 shares of worth nearly -. BANK OF AMERICA CORP /DE/ also lessened -100% of the SONN shares from its portfolio, reducing its holding to 0 shares of worth -. WELLS FARGO & COMPANY/MN also shunned SONN shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in SONN by 12.26% in the last quarter. The institutional holder raised its holding to 1.89 million shares having worth more than $529.00K. GEODE CAPITAL MANAGEMENT, LLC also added 9.39% more shares of SONN to its portfolio, raising its holding to 727.64 thousand shares of worth $203.00K. ADVISORY SERVICES NETWORK, LLC also increased its SONN shares holding by 158.34% which brought its holding to 130.53 thousand shares worth $37.00K.

The insider with the most stakes in SONN is Mohan Pankaj , Chairman, President and CEO at the company. Additionally, SONN stock is highly held by Chief Medical Officer Kenney Richard T and SPITCAUFSKY LARRY among others.

Company executives, directors, and other insiders own 1.38% percent of Sonnet BioTherapeutics Holdings, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SONN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include SPITCAUFSKY LARRY.

There have been 0 transaction(s) during the past 6-months in which Sonnet BioTherapeutics Holdings, Inc. insiders have bought stock, totalling 0 shares

Around 0 Sonnet BioTherapeutics Holdings, Inc. shares are held by insiders, which represents about 1.38% of SONN stock.

SONN Chairman, President and CEO, Mohan Pankaj holds the largest portfolio of the company's shares. SONN shares owned by Mohan total nearly 59.53 thousand.

TOWER RESEARCH CAPITAL LLC (TRC) is the largest institutional owner in SONN which holds 0 shares worth - or 0% of the total SONN shares outstanding followed by BANK OF AMERICA CORP /DE/ with ownership of 0 shares representing 0% of the SONN ownership. WELLS FARGO & COMPANY/MN is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SONN is concerned, it is a stock which is not optionable.

Number of SONN shares short is 40.12K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 3.01M shares of SONN are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SONN has 585.99K shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SONN is 0.03.